Aura Biosciences Debt-to-Equity Ratio Growth & History (AURA)

Aura Biosciences's debt-to-equity ratio was 0.13 for fiscal 2025.

View full Aura Biosciences company overview

Aura Biosciences annual debt-to-equity ratio history

Aura Biosciences annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.130.00+2.77%
20242024-12-310.120.04+42.63%
20232023-12-310.09−0.02−18.80%
20222022-12-310.110.10+1566.02%
20212021-12-310.01

Aura Biosciences debt-to-equity ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Aura Biosciences's debt-to-equity ratio increased from 0.01 to 0.13, a change of 0.12. The latest reported quarter, Q2 2026, shows 0.05.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Aura Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about AURA yet. Start the conversation.

Write the first post